Regulation of Smooth Muscle Cell Differentiation by RhoA
RhoA 对平滑肌细胞分化的调节
基本信息
- 批准号:6747567
- 负责人:
- 金额:$ 28.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:actin binding proteinangiotensin IIbiological signal transductioncell differentiationcell growth regulationfungal proteinsgel mobility shift assaygene expressiongenetic promoter elementgenetically modified animalsguanine nucleotide binding proteinimmunoprecipitationintegrinslaboratory mousemuscle cellsphenotypephosphorylationprotein protein interactionreporter genesthrombintissue /cell culturetranscription factorvascular smooth muscleyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Vascular smooth muscle cell (SMC) differentiation is a very important process during vasculogenesis and angiogenesis, and it is recognized that alterations in SMC phenotype play a role in the progression of several prominent cardiovascular diseases including atherosclerosis, hypertension, and restenosis. The overall goal of the proposed studies is to identify the mechanisms by which environmental signals regulate SMC differentiation marker gene expression. Serum response factor (SRF) is the only transcription factor that has been shown to regulate all of the SMC differentiation marker genes. Since RhoA regulates SRF, and because RhoA activity is affected by many environmental cues (matrix, contractile agonists, growth factors, mechanical stretch) we hypothesize that Rho signaling is important for regulating SMC-specific transcription, and ultimately, SMC phenotype. Our specific aims are as follows: Aim 1 - to identify the Rho-dependent signaling pathways that contribute to the regulation of SMC-specific gene expression. We will measure Rho activation in SMC, and we will use dominant negative approaches to determine the extent to which Rho and Rho effectors contribute to the regulation of SMC-specific promoter/reporter constructs. Aim 2 - to identify the mechanisms by which Rho affects SRF-dependent transcription in SMC. We will study the effects of Rho on the regulation of SRF phosphorylation and DNA binding, and on SRF's interaction with other transcription factors. Aim 3 - to determine the effects of RhoA signaling on SMC differentiation in vivo. Because SMC phenotype is regulated by many diverse environmental cues that cannot be accurately reproduced in culture models, it is important to study SMC differentiation in vivo. We will express dominant negative and constitutively active forms of Rho specifically in SMC in mice using the SM myosin heavy chain promoter. Measuring SMC differentiation marker gene expression, examining vessel and organ morphology, and determining proliferation indices will assess effects on SMC differentiation. Completion of these aims should lead to a better understanding of the signaling and transcription mechanisms that regulate SMC differentiation and perhaps to novel targets for cardiovascular therapeutic intervention.
描述(申请人提供):血管平滑肌细胞(SMC)分化是血管发生和血管生成过程中非常重要的过程,并且人们认识到SMC表型的改变在包括动脉粥样硬化、高血压和再狭窄在内的几种重要心血管疾病的进展中发挥作用。拟议研究的总体目标是确定环境信号调节 SMC 分化标记基因表达的机制。血清反应因子 (SRF) 是唯一已被证明可以调节所有 SMC 分化标记基因的转录因子。由于 RhoA 调节 SRF,并且 RhoA 活性受到许多环境因素(基质、收缩激动剂、生长因子、机械拉伸)的影响,我们假设 Rho 信号对于调节 SMC 特异性转录以及最终调节 SMC 表型非常重要。我们的具体目标如下: 目标 1 - 确定有助于调节 SMC 特异性基因表达的 Rho 依赖性信号通路。我们将测量 SMC 中的 Rho 激活,并使用显性失活方法来确定 Rho 和 Rho 效应子对 SMC 特异性启动子/报告基因构建体调节的贡献程度。目标 2 - 确定 Rho 影响 SMC 中 SRF 依赖性转录的机制。我们将研究 Rho 对 SRF 磷酸化和 DNA 结合的调节以及 SRF 与其他转录因子相互作用的影响。目标 3 - 确定 RhoA 信号传导对 SMC 体内分化的影响。由于 SMC 表型受到许多不同环境因素的调节,而这些环境因素无法在培养模型中准确再现,因此研究 SMC 体内分化非常重要。我们将使用 SM 肌球蛋白重链启动子在小鼠 SMC 中特异性表达 Rho 的显性失活和组成型活性形式。测量 SMC 分化标志物基因表达、检查血管和器官形态并确定增殖指数将评估对 SMC 分化的影响。完成这些目标应该可以更好地理解调节 SMC 分化的信号传导和转录机制,并可能导致心血管治疗干预的新靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher P. Mack其他文献
GRAF1 deficiency leads to defective brown adipose tissue differentiation and thermogenic response
- DOI:
10.1038/s41598-024-79301-6 - 发表时间:
2024-11-20 - 期刊:
- 影响因子:3.900
- 作者:
Xue Bai;Qiang Zhu;Matthew Combs;Martin Wabitsch;Christopher P. Mack;Joan M. Taylor - 通讯作者:
Joan M. Taylor
Christopher P. Mack的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher P. Mack', 18)}}的其他基金
Atheroprotection by smooth muscle selective RhoGAPs
平滑肌选择性 RhoGAP 的动脉粥样硬化保护作用
- 批准号:
10540001 - 财政年份:2022
- 资助金额:
$ 28.97万 - 项目类别:
Atheroprotection by smooth muscle selective RhoGAPs
平滑肌选择性 RhoGAP 的动脉粥样硬化保护作用
- 批准号:
10670403 - 财政年份:2022
- 资助金额:
$ 28.97万 - 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
- 批准号:
8297230 - 财政年份:2012
- 资助金额:
$ 28.97万 - 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
- 批准号:
8644311 - 财政年份:2012
- 资助金额:
$ 28.97万 - 项目类别:
Genetic and epigenetic regulation of vascular smooth muscle cell phenotype and contractility
血管平滑肌细胞表型和收缩性的遗传和表观遗传调控
- 批准号:
10412926 - 财政年份:2012
- 资助金额:
$ 28.97万 - 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
- 批准号:
8452086 - 财政年份:2012
- 资助金额:
$ 28.97万 - 项目类别:
Molecular regulation of the myocardin factors in vascular smooth muscle
血管平滑肌心肌素因子的分子调控
- 批准号:
7860582 - 财政年份:2009
- 资助金额:
$ 28.97万 - 项目类别:
Molecular regulation of the myocardin factors in vascular smooth muscle
血管平滑肌心肌素因子的分子调控
- 批准号:
7583535 - 财政年份:2009
- 资助金额:
$ 28.97万 - 项目类别:
Pre-doctoral Training Program in Integrative Vascular Biology
综合血管生物学博士前培训项目
- 批准号:
9210167 - 财政年份:2002
- 资助金额:
$ 28.97万 - 项目类别:
Pre-doctoral Training Program in Integrative Vascular Biology
综合血管生物学博士前培训项目
- 批准号:
9902485 - 财政年份:2002
- 资助金额:
$ 28.97万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 28.97万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 28.97万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 28.97万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 28.97万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 28.97万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 28.97万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 28.97万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 28.97万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 28.97万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 28.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




